ATLASATLAS fair value
ATLAS has no fair value for this stock today.
OKYO Pharma (OKYO)
OKYO Pharma stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$1.44▲ +2.86%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on OKYO Pharma in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On OKYO Pharma
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives OKYO Pharma a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $1.25 and $1.61; in 9 out of 10, between $1.00 and $2.01. Estimated annual volatility is 65%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $77.1M
- 52-week high
- $3.20
- 52-week low
- $1.26
- Revenue (12 months)
- $0.0M
- Return on equity
- -263.8%
- Free cash flow (12 months)
- $-2.1M
- Beta
- 0.00
What this means
ATLAS does not publish a fair value for OKYO right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks OKYO has traded between $1.26 and $3.20. Today it is 55.0% below that high and 14% above its low.
Its beta is 0.00: it tends to move less than the market.
About the company
OKYO Pharma Ltd. is a clinical-stage biopharmaceutical company focused on developing therapies for neuropathic corneal pain and inflammatory eye diseases.
Want to see everything about OKYO Pharma?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does OKYO Pharma do?
OKYO Pharma Ltd. is a clinical-stage biopharmaceutical company focused on developing therapies for neuropathic corneal pain and inflammatory eye diseases.
What is the chance OKYO goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, OKYO ends the month between $1.25 and $1.61.
How big is OKYO Pharma and what is its P/E ratio?
OKYO Pharma's market capitalization is $77.1M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is OKYO?
ATLAS estimates annual volatility at 65%. In a typical month, half of the outcomes end between $1.25 and $1.61.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer